Allison L. Bayer

2.9k total citations · 1 hit paper
43 papers, 2.4k citations indexed

About

Allison L. Bayer is a scholar working on Immunology, Genetics and Molecular Biology. According to data from OpenAlex, Allison L. Bayer has authored 43 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Immunology, 11 papers in Genetics and 10 papers in Molecular Biology. Recurrent topics in Allison L. Bayer's work include Immune Cell Function and Interaction (22 papers), T-cell and B-cell Immunology (20 papers) and Immunotherapy and Immune Responses (12 papers). Allison L. Bayer is often cited by papers focused on Immune Cell Function and Interaction (22 papers), T-cell and B-cell Immunology (20 papers) and Immunotherapy and Immune Responses (12 papers). Allison L. Bayer collaborates with scholars based in United States, France and Italy. Allison L. Bayer's co-authors include Thomas R. Malek, Aixin Yu, Allen M. Samarel, Maria C. Heidkamp, Dennis O. Adeegbe, Joel W. Martin, Diane M. Eble, Alberto Pugliese, Christopher A. Fraker and Robert B. Levy and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Blood.

In The Last Decade

Allison L. Bayer

42 papers receiving 2.3k citations

Hit Papers

Tolerance, not immunity, crucially depends on IL-2 2004 2026 2011 2018 2004 200 400 600

Peers

Allison L. Bayer
Allison L. Bayer
Citations per year, relative to Allison L. Bayer Allison L. Bayer (= 1×) peers Béatrice Charreau

Countries citing papers authored by Allison L. Bayer

Since Specialization
Citations

This map shows the geographic impact of Allison L. Bayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allison L. Bayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allison L. Bayer more than expected).

Fields of papers citing papers by Allison L. Bayer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allison L. Bayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allison L. Bayer. The network helps show where Allison L. Bayer may publish in the future.

Co-authorship network of co-authors of Allison L. Bayer

This figure shows the co-authorship network connecting the top 25 collaborators of Allison L. Bayer. A scholar is included among the top collaborators of Allison L. Bayer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allison L. Bayer. Allison L. Bayer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fotino, Carmen, R. Damaris Molano, Moufida Ben Nasr, et al.. (2023). Reversal of Experimental Autoimmune Diabetes With an sCD39/Anti-CD3 Treatment. Diabetes. 72(11). 1641–1651. 6 indexed citations
2.
Peters, Leeana D., et al.. (2023). Insulin-like Growth Factor-1 Synergizes with IL-2 to Induce Homeostatic Proliferation of Regulatory T Cells. The Journal of Immunology. 211(7). 1108–1122. 8 indexed citations
3.
Velluto, Diana, et al.. (2022). CCL21 and beta-cell antigen releasing hydrogels as tolerance-inducing therapy in Type I diabetes. Journal of Controlled Release. 348. 499–517. 5 indexed citations
5.
Li, Ying, et al.. (2020). In vitro platform establishes antigen-specific CD8+ T cell cytotoxicity to encapsulated cells via indirect antigen recognition. Biomaterials. 256. 120182–120182. 29 indexed citations
6.
Bayer, Allison L., et al.. (2018). 081 Simvastatin reduces autoimmune alopecia through direct action on T lymphocytes. Journal of Investigative Dermatology. 138(5). S14–S14. 1 indexed citations
7.
Manzoli, Vita, Chiara Villa, Allison L. Bayer, et al.. (2017). Immunoisolation of murine islet allografts in vascularized sites through conformal coating with polyethylene glycol. American Journal of Transplantation. 18(3). 590–603. 48 indexed citations
8.
Fraker, Christopher A. & Allison L. Bayer. (2016). The Expanding Role of Natural Killer Cells in Type 1 Diabetes and Immunotherapy. Current Diabetes Reports. 16(11). 109–109. 26 indexed citations
9.
Yang, Ethan, Joshua P. Kronenfeld, Kerim M. Gattás‐Asfura, Allison L. Bayer, & Cherie L. Stabler. (2015). Engineering an “infectious” Treg biomimetic through chemoselective tethering of TGF-β1 to PEG brush surfaces. Biomaterials. 67. 20–31. 22 indexed citations
10.
Malek, Thomas R., et al.. (2014). In Vivo Environment Necessary to Support Transplanted Donor Mouse T Regulatory Cells. American Journal of Transplantation. 14(5). 1032–1045. 10 indexed citations
11.
Bayer, Allison L., Alberto Pugliese, & Thomas R. Malek. (2013). The IL-2/IL-2R system: from basic science to therapeutic applications to enhance immune regulation. Immunologic Research. 57(1-3). 197–209. 71 indexed citations
12.
Faleo, Gaetano, Carmen Fotino, R. Damaris Molano, et al.. (2012). Prevention of Autoimmune Diabetes and Induction of β-Cell Proliferation in NOD Mice by Hyperbaric Oxygen Therapy. Diabetes. 61(7). 1769–1778. 34 indexed citations
13.
Bayer, Allison L., et al.. (2011). Expansion of a restricted residual host Treg‐cell repertoire is dependent on IL‐2 following experimental autologous hematopoietic stem transplantation. European Journal of Immunology. 41(12). 3467–3478. 14 indexed citations
14.
Bayer, Allison L., et al.. (2008). A Function for IL-7R for CD4+CD25+Foxp3+ T Regulatory Cells. The Journal of Immunology. 181(1). 225–234. 116 indexed citations
15.
Adeegbe, Dennis O., Allison L. Bayer, Robert B. Levy, & Thomas R. Malek. (2006). Cutting Edge: Allogeneic CD4+CD25+Foxp3+ T Regulatory Cells Suppress Autoimmunity while Establishing Transplantation Tolerance. The Journal of Immunology. 176(12). 7149–7153. 62 indexed citations
16.
Bayer, Allison L., Aixin Yu, Dennis O. Adeegbe, & Thomas R. Malek. (2005). Essential role for interleukin-2 for CD4+CD25+ T regulatory cell development during the neonatal period. The Journal of Experimental Medicine. 201(5). 769–777. 205 indexed citations
17.
Woodward, Jennifer, Allison L. Bayer, & Prabhakar K. Baliga. (1999). ENHANCED ALLOGRAFT SURVIVAL VIA SIMULTANEOUS BLOCKADE OF TRANSFERRIN RECEPTOR AND INTERLEUKIN-2 RECEPTOR1. Transplantation. 68(9). 1369–1376. 3 indexed citations
18.
Woodward, Jennifer, et al.. (1998). T-CELL ALTERATIONS IN CARDIAC ALLOGRAFT RECIPIENTS AFTER B7 (CD80 AND CD86) BLOCKADE1. Transplantation. 66(1). 14–20. 14 indexed citations
19.
Bayer, Allison L., Prabhakar K. Baliga, & Jennifer Woodward. (1998). Transferrin receptor in T cell activation and transplantation. Journal of Leukocyte Biology. 64(1). 19–24. 28 indexed citations
20.
Woodward, Jennifer, et al.. (1998). ANTI-TRANSFERRIN RECEPTOR MONOCLONAL ANTIBODY. Transplantation. 65(1). 6–9. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026